AI Earnings Predictions for Glaukos Corporation (GKOS)

Glaukos Corporation_February 17, 2026 0001192448false00011924482026-02-172026-02-17 ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

​

CURRENT REPORT

​ Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): February 17, 2026

Glaukos Corporation (Exact name of registrant as specified in its charter)

​

Delaware ​ ​ ​ 001-37463 ​ ​ ​ 33-0945406

(State or other jurisdiction ​ (Commission ​ (I.R.S. Employer

of incorporation) ​ File Number) ​ Identification No.)

​ ​

One Glaukos Way ​ ​ ​

Aliso Viejo ​ ​

California ​ 92656

(Address of principal executive offices)

(Zip Code)

​ Registrant’s telephone number, including area code: (949) 367-9600 ​ Not Applicable (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class: ​ ​ ​ Trading Symbol ​ ​ ​ Name of each exchange on which registered:

Common Stock ​

GKOS

​ New York Stock Exchange

​ Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition.

On February 17, 2026, Glaukos Corporation (the “Company”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing. ​ ​ Item 7.01. Regulation FD Disclosure.

A Quarterly Summary containing supplemental business and financial information for the Company’s fourth quarter and fiscal year ended December 31, 2025 is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Quarterly Summary is also available in the “Financials & Filings” section of the Company’s investor relations website at https://investors.glaukos.com. ​ The information contained in this Item 7.01 and in the accompanying Exhibit 99.2 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing. ​ ​ Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

​

​

​

Exhibit No. ​ ​ ​ Description

99.1

Press Release of Glaukos Corporation, dated February 17, 2026

​ ​ ​

99.2 ​ Quarterly Summary of Glaukos Corporation for the fourth quarter and fiscal year ended December 31, 2025

​ ​ ​

104 ​ Cover Page Interactive Data File (embedded within the Inline XBRL document)

​ ​ ​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ​

GLAUKOS CORPORATION

(Registrant)

​ ​

By: /s/ Alex R. Thurman

Name: Alex R. Thurman

Title: Senior Vice President & Chief Financial Officer

Date: February 17, 2026 ​ ​ ​

Glaukos Corporation_January 13, 2026 0001192448false00011924482026-01-132026-01-13 ​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

​

CURRENT REPORT

​ Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): January 13, 2026

Glaukos Corporation (Exact name of registrant as specified in its charter)

​ Delaware ​ ​ ​ 001-37463 ​ ​ ​ 33-0945406

(State or other jurisdiction ​ (Commission ​ (I.R.S. Employer

of incorporation) ​ File Number) ​ Identification No.)

​ ​ One Glaukos Way Aliso Viejo, California ​ ​ ​ 92656

​ ​ ​

(Address of principal executive offices)

(Zip Code)

​ Registrant’s telephone number, including area code: (949) 367-9600 ​ Not Applicable (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Securities registered pursuant to Section 12(b) of the Act:

Title of each class: ​ ​ ​ Trading Symbol ​ ​ ​ Name of each exchange on which registered:

Common Stock ​

GKOS

​ New York Stock Exchange

​ ​ ​ ​ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition. ​ On January 13, 2026, Glaukos Corporation (the “Company”) issued a press release announcing its preliminary, unaudited net sales results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. ​ The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing. ​ ​ Item 7.01. Regulation FD Disclosure. The Company intends to present the materials attached as Exhibit 99.2 to this Current Report on Form 8-K (the “Investor Presentation”) from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company’s website at http://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.2 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing. ​ Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. ​ ​ ​ Description

99.1 ​ Press Release of Glaukos Corporation dated January 13, 2026

99.2

Investor Presentation, dated January 2026

104 ​ Cover Page Interactive Data File (embedded within the Inline XBRL document)

​ ​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GLAUKOS CORPORATION

(Registrant)

​ ​

By: /s/ Alex R. Thurman

Name:     Alex R. Thurman

Title:       Senior Vice President & Chief Financial Officer

​ Date: January 13, 2026 ​ ​

Glaukos Corporation_October 29, 2025 0001192448false00011924482025-10-292025-10-29 ​ ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

​ Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): October 29, 2025

Glaukos Corporation (Exact name of registrant as specified in its charter)

​

Delaware

001-37463

33-0945406

(State or other jurisdiction ​ (Commission ​ (I.R.S. Employer

of incorporation) ​ File Number) ​ Identification No.)

​ ​

One Glaukos Way

Aliso Viejo ​ ​

California ​ 92656

(Address of principal executive offices)

(Zip Code)

​ Registrant’s telephone number, including area code: (949) 367-9600 ​ (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class:

Trading Symbol

Name of each exchange on which registered:

Common Stock ​

GKOS

​ New York Stock Exchange

​ Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ ​ ​ ​ ​

​

Item 2.02. Results of Operations and Financial Condition. On October 29, 2025, Glaukos Corporation (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing. ​ Item 7.01. Regulation FD Disclosure. A Quarterly Summary containing supplemental business and financial information for the Company’s third quarter ended September 30, 2025 is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Quarterly Summary is also available in the “Financials & Filings” section of the Company’s investor relations website at https://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.2 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing. ​ Item 9.01. Financial Statements and Exhibits. (d) Exhibits. ​

​

​

Exhibit No.

Description

99.1

Press Release of Glaukos Corporation, dated October 29, 2025

​ ​ ​

99.2 ​ Quarterly Summary of Glaukos Corporation for the third quarter ended September 30, 2025

​ ​ ​

104 ​ Cover Page Interactive Data File (embedded within the Inline XBRL document)

​ ​

​

​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GLAUKOS CORPORATION

(Registrant)

​ ​

By: /s/ Alex R. Thurman

Name: Alex R. Thurman

Title: Senior Vice President & Chief Financial Officer

​ Date: October 29, 2025 ​

​